跳至主要内容
临床试验/JPRN-UMIN000002488
JPRN-UMIN000002488已完成3 期

A randomized controlled trial of stereotactic body radiation therapy (SBRT) with radiofrequency ablation (RFA) for small hepatocellular carcinoma - A randomized controlled trial of SBRT with RFA for small hepatocellular carcinoma

Department of Gastroenterology, National Hospital Organization, Kyoto Medical Center0 个研究点目标入组 288 人开始时间: 2009年9月16日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
288

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) Active infectious disease requiring treatment (2) In pregnancy or lactation, or with expectation of pregnancy (3) History of irradiation to body trunk for any disease (4) Implantation of a permanent pacemaker (5) Tumors abutting the stomach or intestinal loop (6) Simultaneous malignancies

研究者

发起方
Department of Gastroenterology, National Hospital Organization, Kyoto Medical Center

相似试验

进行中(未招募)
1 期
A phase 2 trial for patients with metastatic prostate cancer to study treatment with nivolumab and ipilimumab with or without radiotherapymetastatic castration-resistant prostate cancerMedDRA version: 21.1Level: PTClassification code 10036909Term: Prostate cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10036920Term: Prostate cancer stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.1Level: LLTClassification code 10076506Term: Castration-resistant prostate cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2018-003461-34-DKDepartment of Oncology, Herlev & Gentofte Hospital90
进行中(未招募)
1 期
Prostate cancer with OligometaSTatic relapse: Combining stereotactic Ablative Radiotherapy and Durvalumab (MEDI4736), a randomized phase II trial
CTIS2024-513207-13-00Institut De Cancerologie De L Ouest96
已完成
1 期
A phase I clinical trial of stereotactic body radiotherapy for patients with cervical cancer unsuitable for intracavitary brachytherapyCervical cancer
JPRN-UMIN000020519Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital12
终止
不适用
A Trial on SBRT After Incomplete TAE or TACE Versus Exclusive TAE or TACE For Treatment of Inoperable HCCHepatocellular Carcinoma
NCT02323360Istituto Clinico Humanitas41
已完成
2 期
Prospective phase II study of stereotactic body radiation therapy using helical tomotherapy for stage IA non-small cell lung cancer.stage IA non-small cell lung cancer
JPRN-UMIN000001721Aichi Cancer Center Hospital50